Valentine Moya Macaulay

6PUBLICATIONS
9CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Gene expression (incl. microarray and other genome-wide approaches)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 03, 2023
A Phase Ib/II study of IGF-neutralising antibody xentuzumab with enzalutamide in metastatic castration-resistant prostate cancer.

Valentine M Macaulay, Simon Lord, Syed Hussain

|Nov 13, 2021
CHK1 inhibition exacerbates replication stress induced by IGF blockade.

Xiaoning Wu, Elena Seraia, Stephanie B Hatch

|Dec 21, 2019
Type 1 IGF receptor associates with adverse outcome and cellular radioresistance in paediatric high-grade glioma.

Aaron D Simpson, Ying Wei Jenetta Soo, Guillaume Rieunier

|Dec 17, 2019
Dual-specificity protein phosphatase DUSP4 regulates response to MEK inhibition in BRAF wild-type melanoma.

Avinash Gupta, Christopher Towers, Frances Willenbrock

|Sep 20, 2019
Radioresistant laryngeal cancers upregulate type 1 IGF receptor and exhibit increased cellular dependence on IGF and EGF signalling.

Ali Qureishi, Guillaume Rieunier, Ketan A Shah

|Feb 02, 2018
RAPTOR up-regulation contributes to resistance of renal cancer cells to PI3K-mTOR inhibition.

Philip Earwaker, Caroline Anderson, Frances Willenbrock

Pageof 1